Active Ingredient: HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
Proprietary Name: SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A087948
Product Number: 001
Approval Date: Feb 22, 1983
Applicant Holder Full Name: PARKE DAVIS DIV WARNER LAMBERT CO
Marketing Status:
Discontinued
Patent and Exclusivity Information
